NCT04245176View on ClinicalTrials.gov

Genetic Testing for All Breast Cancer Patients (GET FACTS)

NAActive, not recruitingINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

January 31, 2020

Primary Completion Date

December 1, 2025

Study Completion Date

December 1, 2025

Conditions
Breast CancerInvasive Breast CancerIn Situ Breast CancerGenetic Testing
Interventions
BEHAVIORAL

Standard Genetic Counseling

Standard genetic counseling: Standard of care discussion

BEHAVIORAL

Quantitative Genetic Counseling

Quantitative genetic counseling: Discussion is guided by tables and graphs.

Trial Locations (1)

02115

Dana Farber Cancer Institute, Boston

Sponsors

Collaborators (1)

Myriad Genetics, Inc.
All Listed Sponsors
collaborator

Myriad Genetics, Inc.

INDUSTRY

lead

Dana-Farber Cancer Institute

OTHER